Orphan Cancer Drugs in the Era of Precision Medicine
Author:
Affiliation:
1. Cardinal Health Specialty Solutions, Cardinal Health, Dublin, Ohio
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Reference10 articles.
1. The Orphan Drug Act.;Sanders;Prog Clin Biol Res,1983
2. Are products with an orphan designation for oncology indications different from products for other rare indications? a retrospective analysis of European orphan designations granted between 2002-2012.;Pauwels;Orphanet J Rare Dis,2017
3. The cost of drug development.;DiMasi;N Engl J Med,2015
4. The Orphan Drug Act: restoring the mission to rare diseases.;Daniel;Am J Clin Oncol,2016
5. Biomarker-defined subsets of common diseases: policy and economic implications of Orphan Drug Act coverage.;Kesselheim;PLoS Med,2017
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical trial evidence supporting FDA approval of novel orphan drugs between 2017 and 2023;Drug Discovery Today;2024-09
2. Clinical Trial Evidence Supporting Fda Approval of Orphan Products between 2017 to 2023;2024
3. Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy;The European Journal of Health Economics;2023-11-14
4. FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis;BMJ;2023-05-09
5. Zukunftspotenziale der Labormedizin;Nutzen der Labormedizin in der Schweiz;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3